Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis

Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Kogieleum Naidoo(Centre for the AIDS Programme of Research in South Africa), Nonhlanhla Yende‐Zuma(Centre for the AIDS Programme of Research in South Africa), Jenine Ramruthan, Mikaila C. Moodley(Centre for the AIDS Programme of Research in South Africa), Upasna Singh(Centre for the AIDS Programme of Research in South Africa)
PLoS ONE
January 29, 2024
10.1371/journal.pone.0297224
Cited by 3

Related Papers

Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis
|International Journal of Epidemiology|2013|204
High Nasopharyngeal Pneumococcal Density, Increased by Viral Coinfection, Is Associated With Invasive Pneumococcal Pneumonia
|The Journal of Infectious Diseases|2014|197
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
|The Lancet HIV|2021|180
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|177
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
|PLoS Medicine|2018|173